137 related articles for article (PubMed ID: 15585913)
1. Isolation and generation of clinical-grade dendritic cells using the CliniMACS system.
Campbell JD; Piechaczek C; Winkels G; Schwamborn E; Micheli D; Hennemann S; Schmitz J
Methods Mol Med; 2005; 109():55-70. PubMed ID: 15585913
[TBL] [Abstract][Full Text] [Related]
2. Generation of clinical-grade monocyte-derived dendritic cells using the CliniMACS system.
Putz T; Gander H; Ramoner R; Zelle-Rieser C; Rahm A; Nussbaumer W; Bartsch G; Höltl L; Thurnher M
Methods Mol Med; 2005; 109():71-82. PubMed ID: 15585914
[TBL] [Abstract][Full Text] [Related]
3. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
[TBL] [Abstract][Full Text] [Related]
4. Efficiency and Impact of Positive and Negative Magnetic Separation on Monocyte Derived Dendritic Cell Generation.
Kowalewicz-Kulbat M; Ograczyk E; Włodarczyk M; Krawczyk K; Fol M
Iran J Immunol; 2016 Jun; 13(2):132-40. PubMed ID: 27350634
[TBL] [Abstract][Full Text] [Related]
5. Comparison of monocyte enrichment by immuno-magnetic depletion or adherence for the clinical-scale generation of DC.
Suen Y; Lee SM; Aono F; Hou S; Loudovaris M; Ofstein G; Bender JG
Cytotherapy; 2001; 3(5):365-75. PubMed ID: 11953016
[TBL] [Abstract][Full Text] [Related]
6. The Isolation and Enrichment of Large Numbers of Highly Purified Mouse Spleen Dendritic Cell Populations and Their In Vitro Equivalents.
Vremec D
Methods Mol Biol; 2016; 1423():61-87. PubMed ID: 27142009
[TBL] [Abstract][Full Text] [Related]
7. Large-scale monocyte enrichment coupled with a closed culture system for the generation of human dendritic cells.
Pullarkat V; Lau R; Lee SM; Bender JG; Weber JS
J Immunol Methods; 2002 Sep; 267(2):173-83. PubMed ID: 12165439
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of dendritic cell generation for clinical use: recovery and purity of monocytes and mature dendritic cells after immunomagnetic sorting or adherence selection of CD14+ starting populations.
Meyer-Wentrup F; Burdach S
J Hematother Stem Cell Res; 2003 Jun; 12(3):289-99. PubMed ID: 12857370
[TBL] [Abstract][Full Text] [Related]
9. Generation of a dendritic cell-based vaccine in chronic lymphocytic leukaemia using CliniMACS platform for large-scale production.
Adamson L; Palma M; Choudhury A; Eriksson I; Näsman-Glaser B; Hansson M; Hansson L; Kokhaei P; Osterborg A; Mellstedt H
Scand J Immunol; 2009 Jun; 69(6):529-36. PubMed ID: 19439014
[TBL] [Abstract][Full Text] [Related]
10. Generation of dendritic cells from CD14+ monocytes positively selected by immunomagnetic adsorption for multiple myeloma patients enrolled in a clinical trial of anti-idiotype vaccination.
Motta MR; Castellani S; Rizzi S; Curti A; Gubinelli F; Fogli M; Ferri E; Cellini C; Baccarani M; Lemoli RM
Br J Haematol; 2003 Apr; 121(2):240-50. PubMed ID: 12694245
[TBL] [Abstract][Full Text] [Related]
11. Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4.
Kiertscher SM; Roth MD
J Leukoc Biol; 1996 Feb; 59(2):208-18. PubMed ID: 8603993
[TBL] [Abstract][Full Text] [Related]
12. Isolation of human blood DC subtypes.
Kassianos AJ; Jongbloed SL; Hart DN; Radford KJ
Methods Mol Biol; 2010; 595():45-54. PubMed ID: 19941104
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of monocytic cell clones into CD8 alpha+ dendritic cells (DC) suggests that monocytes can be direct precursors for both CD8 alpha+ and CD8 alpha- DC in the mouse.
Gao JX; Liu X; Wen J; Zhang H; Durbin J; Liu Y; Zheng P
J Immunol; 2003 Jun; 170(12):5927-35. PubMed ID: 12794119
[TBL] [Abstract][Full Text] [Related]
14. A protocol for rapid monocyte isolation and generation of singular human monocyte-derived dendritic cells.
Chometon TQ; Siqueira MDS; Sant Anna JC; Almeida MR; Gandini M; Martins de Almeida Nogueira AC; Antas PRZ
PLoS One; 2020; 15(4):e0231132. PubMed ID: 32271804
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of human peripheral blood dendritic cells.
Thomas R; Davis LS; Lipsky PE
J Immunol; 1993 Feb; 150(3):821-34. PubMed ID: 7678623
[TBL] [Abstract][Full Text] [Related]
16. Functional and phenotypic analysis of thymic CD34+CD1a- progenitor-derived dendritic cells: predominance of CD1a+ differentiation pathway.
Dalloul AH; Patry C; Salamero J; Canque B; Grassi F; Schmitt C
J Immunol; 1999 May; 162(10):5821-8. PubMed ID: 10229816
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of two separation methods to isolate monocytes.
Weiss R; Gerdes W; Leonhardt F; Berthold R; Sack U; Grahnert A
Cytometry A; 2019 Feb; 95(2):234-241. PubMed ID: 30378734
[TBL] [Abstract][Full Text] [Related]
18. Unimpaired dendritic cells can be derived from monocytes in old age and can mobilize residual function in senescent T cells.
Lung TL; Saurwein-Teissl M; Parson W; Schönitzer D; Grubeck-Loebenstein B
Vaccine; 2000 Feb; 18(16):1606-12. PubMed ID: 10689136
[TBL] [Abstract][Full Text] [Related]
19. IL-4 and CD40 ligation affect differently the differentiation, maturation, and function of human CD34+ cell-derived CD1a+CD14- and CD1a-CD14+ dendritic cell precursors in vitro.
Canque B; Camus S; Yagello M; Gluckman JC
J Leukoc Biol; 1998 Aug; 64(2):235-44. PubMed ID: 9715264
[TBL] [Abstract][Full Text] [Related]
20. Clinical-grade manufacturing of DC from CD14+ precursors: experience from phase I clinical trials in CML and malignant melanoma.
Dietz AB; Padley DJ; Butler GW; Maas ML; Greiner CW; Gastineau DA; Vuk-Pavlović S
Cytotherapy; 2004; 6(6):563-70. PubMed ID: 15773024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
